These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 17182219)
1. Homocysteine: an activity marker in Behçet's disease? Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219 [TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine level and uveitis in Behçet's disease. Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183 [TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study. Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874 [TBL] [Abstract][Full Text] [Related]
4. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease. Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123 [TBL] [Abstract][Full Text] [Related]
6. Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878 [TBL] [Abstract][Full Text] [Related]
7. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up. Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630 [TBL] [Abstract][Full Text] [Related]
8. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
9. Increased serum ferritin levels in active Behçet's disease. Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217 [TBL] [Abstract][Full Text] [Related]
10. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease. Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545 [TBL] [Abstract][Full Text] [Related]
11. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease? Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine in vascular Behcet disease: a meta-analysis. La Regina M; Orlandini F; Prisco D; Dentali F Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474 [TBL] [Abstract][Full Text] [Related]
13. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013 [TBL] [Abstract][Full Text] [Related]
14. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity. Aki T; Karincaoglu Y; Seyhan M; Batcioglu K Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167 [TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis. Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001 [TBL] [Abstract][Full Text] [Related]
16. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications. Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346 [TBL] [Abstract][Full Text] [Related]